Surgical removal of inflamed epididymal white adipose tissue attenuates the development of non-alcoholic steatohepatitis in obesity.
about
The Angiogenesis Inhibitor ALS-L1023 from Lemon-Balm Leaves Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease through Regulating the Visceral Adipose-Tissue Function.A casein hydrolysate based formulation attenuates obesity and associated non-alcoholic fatty liver disease and atherosclerosis in LDLr-/-.Leiden mice.Intervention with a caspase-1 inhibitor reduces obesity-associated hyperinsulinemia, non-alcoholic steatohepatitis and hepatic fibrosis in LDLR-/-.Leiden mice.The CCR2 Inhibitor Propagermanium Attenuates Diet-Induced Insulin Resistance, Adipose Tissue Inflammation and Non-Alcoholic Steatohepatitis.Reduction of obesity-associated white adipose tissue inflammation by rosiglitazone is associated with reduced non-alcoholic fatty liver disease in LDLr-deficient mice.Prolonged high-fat diet induces gradual and fat depot-specific DNA methylation changes in adult mice.Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies.Butyrate restores HFD-induced adaptations in brain function and metabolism in mid-adult obese mice.Effects of Anthocyanin and Flavanol Compounds on Lipid Metabolism and Adipose Tissue Associated Systemic Inflammation in Diet-Induced Obesity.Butyrate Reduces HFD-Induced Adipocyte Hypertrophy and Metabolic Risk Factors in Obese LDLr-/-.Leiden Mice.Adipocyte JAK2 Regulates Hepatic Insulin Sensitivity Independently of Body Composition, Liver Lipid Content, and Hepatic Insulin Signaling.Increased intake of energy-dense diet and negative energy balance in a mouse model of chronic psychosocial defeat.The Inhibitory Effects of Purple Sweet Potato Color on Hepatic Inflammation Is Associated with Restoration of NAD⁺ Levels and Attenuation of NLRP3 Inflammasome Activation in High-Fat-Diet-Treated Mice.
P2860
Q33624836-7B9FB533-3028-466B-955B-5B9A64D345A8Q33874197-9A264AF1-003C-406A-979D-2837FD4EA8F9Q34523876-3C9B78A6-9B17-4873-9685-94F86E9C6581Q36246407-AE97DA53-CF7C-40AA-8691-5EE82D1954A4Q37193179-8B0791A3-0652-4504-A9CD-08656E5BFEF7Q37678973-D2BE76A7-D3C4-4083-9E0E-EC15BBFECE85Q38791485-BC25F69B-C406-45B8-8AE7-2216ED33F061Q38951126-3E088AC3-72DC-49A1-A26F-D32685C17705Q40672274-419EB57A-5F1B-42E6-B9F1-F90B556B6F08Q41195209-89E7B0D3-55AD-41F1-A44C-FCBC2F071321Q46255295-7FF91F33-D07F-44D4-AB65-4BFEEFCEC1F4Q47951849-F9BCE890-28F4-4751-8C06-17AFD9110B37Q54758453-45C02151-89A9-4678-8A82-4CD37ADCC874
P2860
Surgical removal of inflamed epididymal white adipose tissue attenuates the development of non-alcoholic steatohepatitis in obesity.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Surgical removal of inflamed e ...... ic steatohepatitis in obesity.
@en
type
label
Surgical removal of inflamed e ...... ic steatohepatitis in obesity.
@en
prefLabel
Surgical removal of inflamed e ...... ic steatohepatitis in obesity.
@en
P2093
P2860
P356
P1476
Surgical removal of inflamed e ...... lic steatohepatitis in obesity
@en
P2093
P Y Wielinga
R Kleemann
T Kooistra
W van Duyvenvoorde
P2860
P2888
P304
P356
10.1038/IJO.2015.226
P407
P577
2015-10-26T00:00:00Z